BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4591038)

  • 41. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans.
    Watamoto T; Samaranayake LP; Jayatilake JA; Egusa H; Yatani H; Seneviratne CJ
    Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Econazole effects on Trichophyton rubrum and Candida albicans--electron microscopic and cytochemical studies.
    Preusser HJ; Rostek H
    Mykosen Suppl; 1978; 1():314-21. PubMed ID: 400880
    [No Abstract]   [Full Text] [Related]  

  • 43. [Interactions between antimycetic imidazole derivatives and lipids, waxes and triterpenes (author's transl)].
    Högl F; Raab W
    Mykosen; 1980 Dec; 23(12):669-81. PubMed ID: 7012611
    [No Abstract]   [Full Text] [Related]  

  • 44. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
    Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
    J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antifungal and antimycobacterial activity of 1-(3,5-diaryl-4,5-dihydro-1H-pyrazol-4-yl)-1H-imidazole derivatives.
    Zampieri D; Mamolo MG; Laurini E; Scialino G; Banfi E; Vio L
    Bioorg Med Chem; 2008 Apr; 16(8):4516-22. PubMed ID: 18321714
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In situ TEM and SEM studies on the antimicrobial activity and prevention of Candida albicans biofilm by Cassia spectabilis extract.
    Sangetha S; Zuraini Z; Suryani S; Sasidharan S
    Micron; 2009 Jun; 40(4):439-43. PubMed ID: 19261482
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Interactions between 5-fluorocytosine and polyene antibiotics, resp. imidazole derivatives (author's transl)].
    Högl F; Raab W
    Mykosen; 1981 May; 24(5):261-74. PubMed ID: 6265772
    [No Abstract]   [Full Text] [Related]  

  • 48. [Synthesis of derivatives of 2-imidazolyl-l-indanol and of 2-imidazolyl-l-tetralol with antifungal activity [(author's transl)]].
    Strehlke P; Hoyer GA; Schröder E
    Arch Pharm (Weinheim); 1975 Feb; 308(2):94-109. PubMed ID: 1093508
    [No Abstract]   [Full Text] [Related]  

  • 49. Evaluation of the antifungal activity of fenticonazole on strains of Candida albicans on cellular lines.
    Cusumano V; Costa AL; Veronese M
    Mykosen; 1985 May; 28(5):238-43. PubMed ID: 3892289
    [No Abstract]   [Full Text] [Related]  

  • 50. Combined activity of ketoconazole and sulphamethoxazole against Candida albicans.
    Beggs WH
    J Antimicrob Chemother; 1982 Dec; 10(6):539-41. PubMed ID: 6298174
    [No Abstract]   [Full Text] [Related]  

  • 51. Clotrimazole (Bay b 5097): in vitro and clinical pharmacological studies.
    Burgess MA; Bodey GP
    Antimicrob Agents Chemother; 1972 Dec; 2(6):423-6. PubMed ID: 4677595
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of ketoconazole on the initial stages of germ tube formation by strains of Candida albicans.
    Johnson EM; Barnard ML; Richardson MD; Warnock DW
    Mykosen; 1982 Sep; 25(9):481-6. PubMed ID: 6292712
    [No Abstract]   [Full Text] [Related]  

  • 53. Mode of action of clinically important antifungal drugs.
    Kerridge D
    Adv Microb Physiol; 1986; 27():1-72. PubMed ID: 3532715
    [No Abstract]   [Full Text] [Related]  

  • 54. Surface morphology of Candida albicans after treatment with antimycotic drugs.
    Anséhn S; Winblad B
    Mykosen Suppl; 1978; 1():322-7. PubMed ID: 400881
    [No Abstract]   [Full Text] [Related]  

  • 55. Direct fungicidal action of tioconazole.
    Beggs WH
    Ann N Y Acad Sci; 1988; 544():354-6. PubMed ID: 3063175
    [No Abstract]   [Full Text] [Related]  

  • 56. Antagonisms of potential concern in the clinical use of antifungal imidazoles and related azole-type drugs.
    Beggs WH
    Mycopathologia; 1992 Dec; 120(3):131-2. PubMed ID: 1494356
    [No Abstract]   [Full Text] [Related]  

  • 57. Antifungal properties and target evaluation of three putative bacterial histidine kinase inhibitors.
    Deschenes RJ; Lin H; Ault AD; Fassler JS
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1700-3. PubMed ID: 10390225
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Imidazolyl derivatives in medicinal chemistry.
    Carganico G; Cozzi P
    Farmaco; 1991 Jan; 46(1 Suppl):209-31. PubMed ID: 1854404
    [No Abstract]   [Full Text] [Related]  

  • 59. Imidazole: fungitoxic derivatives.
    Tolkmith H; Seiber JN; Budde PB; Mussell DR
    Science; 1967 Dec; 158(3807):1462-3. PubMed ID: 6058685
    [TBL] [Abstract][Full Text] [Related]  

  • 60. STUDIES ON THE FINE STRUCTURE OF CANDIDA ALBICANS CELL, WITH SPECIAL REFERENCE TO THE NUCLEAR SITE.
    FUJINO T; AKITA Y; OKADA M
    Biken J; 1965 Apr; 8():1-5. PubMed ID: 14340034
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.